Phibro Animal Health (NASDAQ:PAHC) Reaches New 1-Year High on Analyst Upgrade

Shares of Phibro Animal Health Co. (NASDAQ:PAHC) hit a new 52-week high during trading on Tuesday after Barclays raised their price target on the stock from $20.00 to $22.00. Barclays currently has an underweight rating on the stock. Phibro Animal Health traded as high as $26.42 and last traded at $26.22, with a volume of 874178 shares traded. The stock had previously closed at $23.69.

Several other research firms also recently commented on PAHC. Morgan Stanley raised their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 6th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, Phibro Animal Health has an average rating of “Hold” and an average target price of $21.00.

Hedge Funds Weigh In On Phibro Animal Health

Institutional investors have recently bought and sold shares of the business. Quantbot Technologies LP bought a new position in Phibro Animal Health in the 3rd quarter valued at $70,000. nVerses Capital LLC bought a new position in Phibro Animal Health in the 3rd quarter valued at $70,000. China Universal Asset Management Co. Ltd. raised its position in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the last quarter. New York State Teachers Retirement System raised its position in Phibro Animal Health by 16.7% in the 4th quarter. New York State Teachers Retirement System now owns 5,428 shares of the company’s stock valued at $114,000 after purchasing an additional 775 shares during the last quarter. Finally, CWM LLC raised its position in Phibro Animal Health by 190.8% in the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock valued at $143,000 after purchasing an additional 4,175 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Trading Up 10.7 %

The company has a 50-day simple moving average of $21.90 and a 200-day simple moving average of $21.70. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.69 and a current ratio of 3.20. The stock has a market cap of $1.06 billion, a P/E ratio of 54.63, a P/E/G ratio of 0.53 and a beta of 0.52.

Phibro Animal Health (NASDAQ:PAHC) last released its earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, sell-side analysts forecast that Phibro Animal Health Co. will post 1.94 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be paid a $0.12 dividend. The ex-dividend date is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 1.83%. Phibro Animal Health’s dividend payout ratio (DPR) is currently 100.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.